BCTXNasdaqPharmaceutical PreparationsFiscal year ends July 31Also trades as BCTXL, BCTXZ
BriaCell Therapeutics Corp.
Financials through Q3 FY2026, quarter ended Apr 30, 2026Last filing: 10-Q on Jun 9, 2026
$3.38−0.02 (-0.59%)
Close on Oct 19, 2026
- Market cap
- $24.51M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of BriaCell Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Jun 26, 2026 | Jun 26, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Apr 30, 2026 | Jun 9, 2026 | SEC EDGAR |
| Current report | 8-K | May 31, 2026 | Jun 3, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 31, 2026 | Mar 31, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jan 31, 2026 | Mar 10, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 5, 2026 | Mar 9, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 18, 2026 | Feb 20, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Feb 12, 2026 | Feb 12, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 13, 2026 | Jan 15, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 29, 2025 | Dec 29, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Oct 31, 2025 | Dec 11, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 28, 2025 | Dec 1, 2025 | SEC EDGAR |
| Annual report | 10-K | Jul 31, 2025 | Oct 16, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 21, 2025 | Aug 26, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 15, 2025 | Jul 16, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 16, 2025 | Jun 18, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Apr 30, 2025 | Jun 16, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 24, 2025 | Apr 28, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jan 31, 2025 | Mar 12, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 12, 2025 | Mar 12, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 12, 2025 | Feb 13, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 5, 2025 | Feb 6, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 3, 2025 | Feb 5, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 24, 2025 | Jan 28, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 3, 2025 | Jan 3, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 3, 2025 | Jan 3, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Dec 17, 2024 | Dec 17, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Oct 31, 2024 | Dec 16, 2024 | SEC EDGAR |
| Current report | 8-K | Dec 12, 2024 | Dec 16, 2024 | SEC EDGAR |
| Current report | 8-K | Dec 11, 2024 | Dec 13, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 23, 2024 | Nov 25, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 1, 2024 | Nov 1, 2024 | SEC EDGAR |
| Annual report | 10-K | Jul 31, 2024 | Oct 29, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 1, 2024 | Oct 2, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 1, 2024 | Oct 1, 2024 | SEC EDGAR |
| Current report | 8-K | Sep 11, 2024 | Sep 12, 2024 | SEC EDGAR |
| Current report | 8-K | Sep 9, 2024 | Sep 11, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 22, 2024 | Aug 23, 2024 | SEC EDGAR |
| Current report | 8-K | Jul 18, 2024 | Jul 18, 2024 | SEC EDGAR |
| Current report | 8-K | Jul 3, 2024 | Jul 5, 2024 | SEC EDGAR |